ResearcherScripps Research InstituteNo recent work listed

Virneliz Fernández-Vega

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-2809-6090; OpenAlex author ID A5001446294. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer. Co-author DOI 10.1038/s41419-023-06145-9 ↗
Lead identification using 3D models of pancreatic cancer. Co-author DOI 10.1016/j.slasd.2022.03.002 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Timothy Spicer · 2 shared papers, 2022–2023 · strength 0.31
- Paper A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer. DOI 10.1038/s41419-023-06145-9 ↗
- Paper Lead identification using 3D models of pancreatic cancer. DOI 10.1016/j.slasd.2022.03.002 ↗
Suyakarn Archasappawat · 1 shared paper, 2023 · strength 0.16
- Paper A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer. DOI 10.1038/s41419-023-06145-9 ↗
Eunjung Lee · 1 shared paper, 2023 · strength 0.16
- Paper A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer. DOI 10.1038/s41419-023-06145-9 ↗
Chang‐Il Hwang · 1 shared paper, 2023 · strength 0.16
- Paper A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer. DOI 10.1038/s41419-023-06145-9 ↗
Shurong Hou · 1 shared paper, 2022 · strength 0.15
- Paper Lead identification using 3D models of pancreatic cancer. DOI 10.1016/j.slasd.2022.03.002 ↗
David Arthur Tuveson · 1 shared paper, 2022 · strength 0.15
- Paper Lead identification using 3D models of pancreatic cancer. DOI 10.1016/j.slasd.2022.03.002 ↗
Hervé Tiriac · 1 shared paper, 2022 · strength 0.15
- Paper Lead identification using 3D models of pancreatic cancer. DOI 10.1016/j.slasd.2022.03.002 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.